PMVP · PMV Pharmaceuticals, Inc. · Proposed Sales
$1.39
+0.14 (+10.76%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the Company's current available cash, cash equivalents and marketable securities may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$67.09M
Shares
53.46M
Volume · Oct 20
347.58K
Avg daily vol (3M)
658.75K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-10-23 | OrbiMed Private Investments V, LP | Shareholder | 1,000,000 | 2025-10-23 | Morgan Stanley & Co. LLC |
| 2025-09-10 | OrbiMed Private Investments V, LP | Shareholder | 2,283,654 | 2025-09-10 | Themis Trading LLC |
| 2023-11-22 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 87,786 | 2023-11-22 | Themis Trading LLC |
Showing 1–3 of 3 filings